Optimal Ventilation for Cardiac Arrest
Key facts
- Who runs it
- Children's Hospital of Philadelphia
- Where
- Atlanta, Austin, Boston, Chapel Hill, Cincinnati, Columbus, Dallas, Denver, Indianapolis, Iowa City, Milwaukee, New Hyde Park, Orange, Palo Alto, Philadelphia, Richmond, Seattle, St Louis, and Wilmington, United StatesSee the 20 sites
- Trial code
- Status
- Recruiting
- People taking part
- 1,530 people, planned
- Started
- 1 Oct 2025
- Expected to end
- 31 Mar 2030
- Type of study
- Interventional, 14 groups
- Treatments tested
- OPTI-VENT Bundle
- Transition
- None - control
- Record updated
- 21 October 2026
Who can take part
- Age
- 37 weeks to 18 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Invasive airway in place at the start of CPR or airway placed within the first 5 minutes
- Received at least 1 minute of CPR
Who cannot take part
- Lack of commitment to aggressive ICU therapies (e.g., CPR performed as part of end-of-life care
- Brain death determination prior to the CPR event
- Out-of-hospital cardiac arrest was the reason for initial admission to the hospital (known poor outcomes)
- Supported by Veno-Arterial Extra Corporeal Membrane Oxygenation at the start of CPR
Where in United States
- Children's Healthcare of AtlantaAtlanta, United StatesContact: Stephanie BrownTaking people
- Dell Children's Medical CenterAustin, United StatesContact: Hunter DaigleTaking people
- Boston Children's HospitalBoston, United StatesContact: Catherine RossTaking people
- UNC Children's HospitalChapel Hill, United StatesContact: Afsaneh PirzadehTaking people
- Cincinnati Children's Hospital Medical CenterCincinnati, United StatesContact: Daniel LoebTaking people
- Nationwide Children's HospitalColumbus, United StatesContact: John JenningsTaking people
- Medical City Children's HospitalDallas, United StatesContact: Tia RaymondTaking people
- UT Southwestern Medical CenterDallas, United StatesContact: Priscilla YuTaking people
- Children's Hospital ColoradoDenver, United StatesContact: Lorel HuberTaking people
- Riley Children's HealthIndianapolis, United StatesContact: Maria FrazierTaking people
- Stead Family Children's HospitalIowa City, United StatesContact: Sarah HaskellTaking people
- Children's WisconsinMilwaukee, United StatesContact: Andrea MaxwellTaking people
- Cohen Children's Medical CenterNew Hyde Park, United StatesContact: Todd SwebergTaking people
- CHOCOrange, United StatesContact: Jennifer HayesTaking people
- Lucile Packard Children's Hospital - StanfordPalo Alto, United StatesContact: Azadeh FayaziTaking people
- Children's Hospital of PhiladelphiaPhiladelphia, United StatesContact: Amanda O'HalloranTaking people
- Children's Hospital of Richmond at VCURichmond, United StatesContact: Michelle OlsonTaking people
- Seattle Children'sSeattle, United StatesContact: Joan RobertsTaking people
- Washington University in St. LouisSt Louis, United StatesContact: Ashley TurnerTaking people
- Nemours Children's HealthWilmington, United StatesContact: Yosef LevenbrownTaking people
About the trial
What the trial wants to find out
Pediatric cardiac arrest is a life-threatening problem affecting >15,000 hospitalized children each year. Less than half of these children survive to hospital discharge, and neurologic morbidity is common among survivors. The objective of this study is to evaluate the effectiveness of the OPTI-VENT bundle to improve survival to discharge with favorable neurological outcome (Pediatric Cerebral Performance Category Score 1-2 or no change from baseline) among children receiving at least 1 minute of CPR.
The 14 groups in the trial
- ControlTreatment being tested
Standard ICU resuscitation practices throughout study
Treatment: None - control
- OPTI-VENT BundleTreatment being tested
Provider Education: During a brief (\<2 minute) bedside education, the educator will 1) review the CPR ventilation rate targets for age, and 2) ensure the provider has a cue card of current rate recommendations on his/her person. Compliance will be defined as performance of at least 30 trainings per unit per month. We will record provider discipline and time since last training as a surrogate of training spread. Educators will leverage these two-minute trainings to review the patient's current ventilator settings as an initial target during CPR to ensure adequate chest rise. Additionally, a focus on CPR ventilation rates will be integrated into resuscitation education or quality meetings for all disciplines. "Report cards" detailing unit-level performance will be generated by the study team for review during site monthly presentations. Point-of-Care Guidance: A metronome will be deployed to all cardiac arrests using a smart phone application.
- Site 5Treatment being tested
Study enrollment will begin on the control arm. There will be a 2-month transition period as they onboard to the intervention. And the remainder of the study period will be on the OPTI-VENT Bundle intervention.
Treatment: OPTI-VENT Bundle, Transition, and None - control
- Site 6Treatment being tested
Study enrollment will begin on the control arm. There will be a 2-month transition period as they onboard to the intervention. And the remainder of the study period will be on the OPTI-VENT Bundle intervention.
Treatment: OPTI-VENT Bundle, Transition, and None - control
- Site 7Treatment being tested
Study enrollment will begin on the control arm. There will be a 2-month transition period as they onboard to the intervention. And the remainder of the study period will be on the OPTI-VENT Bundle intervention.
Treatment: OPTI-VENT Bundle, Transition, and None - control
- Site 8Treatment being tested
Study enrollment will begin on the control arm. There will be a 2-month transition period as they onboard to the intervention. And the remainder of the study period will be on the OPTI-VENT Bundle intervention.
Treatment: OPTI-VENT Bundle, Transition, and None - control
- Site 9Treatment being tested
Study enrollment will begin on the control arm. There will be a 2-month transition period as they onboard to the intervention. And the remainder of the study period will be on the OPTI-VENT Bundle intervention.
Treatment: OPTI-VENT Bundle, Transition, and None - control
- Site 10Treatment being tested
Study enrollment will begin on the control arm. There will be a 2-month transition period as they onboard to the intervention. And the remainder of the study period will be on the OPTI-VENT Bundle intervention.
Treatment: OPTI-VENT Bundle, Transition, and None - control
- Site 11Treatment being tested
Study enrollment will begin on the control arm. There will be a 2-month transition period as they onboard to the intervention. And the remainder of the study period will be on the OPTI-VENT Bundle intervention.
Treatment: OPTI-VENT Bundle, Transition, and None - control
- Site 12Treatment being tested
Study enrollment will begin on the control arm. There will be a 2-month transition period as they onboard to the intervention. And the remainder of the study period will be on the OPTI-VENT Bundle intervention.
Treatment: OPTI-VENT Bundle, Transition, and None - control
- Site 13Treatment being tested
Study enrollment will begin on the control arm. There will be a 2-month transition period as they onboard to the intervention. And the remainder of the study period will be on the OPTI-VENT Bundle intervention.
Treatment: OPTI-VENT Bundle, Transition, and None - control
- Site 14Treatment being tested
Study enrollment will begin on the control arm. There will be a 2-month transition period as they onboard to the intervention. And the remainder of the study period will be on the OPTI-VENT Bundle intervention.
Treatment: OPTI-VENT Bundle, Transition, and None - control
- Site 15Treatment being tested
Study enrollment will begin on the control arm. There will be a 2-month transition period as they onboard to the intervention. And the remainder of the study period will be on the OPTI-VENT Bundle intervention.
Treatment: OPTI-VENT Bundle, Transition, and None - control
- Site 16Treatment being tested
Study enrollment will begin on the control arm. There will be a 2-month transition period as they onboard to the intervention. And the remainder of the study period will be on the OPTI-VENT Bundle intervention.
Treatment: OPTI-VENT Bundle, Transition, and None - control
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- OPTImal Ventilation to Improve Pediatric Cardiac Arrest Outcomes (OPTI-VENT)
- Record updated
- 21 October 2026